Sven A. König-Merediz

A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA

Frank Schakowski, Marcus Gorschlüter, Claas Junghans et al. · Molecular Therapy · 2001 · 99 citations · Full text

Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

Reinhold Schirmbeck, Sven A. König-Merediz, Petra Riedl et al. · Journal of Molecular Medicine · 2001 · 54 citations

B Surface Antigen, Natural Sciences, Humoral Response +8

Expression of Interferon Regulatory Factor 4 in Chronic Myeloid Leukemia: Correlation With Response to Interferon Alfa Therapy

Manuel Schmidt, Andreas Hochhaus, Sven A. König-Merediz et al. · Journal of Clinical Oncology · 2000 · 47 citations

Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703

Manuel Schmidt, Nicole Hagner, Alberto Marco et al. · Nucleic Acid Therapeutics · 2015 · 45 citations · Full text

Single-stranded Oligodeoxynucleotides, Cpg Odn, Innate Immune System +19

Minimal size MIDGE vectors improve transgene expression in vivo.

Frank Schakowski, Marcus Gorschlüter, Peter Buttgereit et al. · PubMed · 2007 · 37 citations

Systemic Transfection, Developmental Biology, Transgene Expression +15